Screener / SEC EDGAR /CIK 0001096343 /10-K filed Feb 26, 2026, compared with Feb 24, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Financials · Property & Casualty Insurance

Markel Group Inc. MKL

Compare with peers Embed
Planned sales, announced before they happen

0 trading plans running, 4 Form 144 notices for $3.3M

10-Q, 10-K and Form 144

What MKL's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.

Plans adopted or ended

Trading plans · XBRL, 10-Q and 10-K

From May 31, 2023 to Nov 16, 2026. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired.

InsiderWhatDateReported in
Steven A. Markel
Chair of the Board of Directors and a Director of the Company
Adopted 10b5-1 plan May 26, 2026 10-Q Jul 29, 2026
What the company wrote
On May 26, 2026, Steven A. Markel, Chair of the Board of Directors and a Director of the Company, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) for the sale of up to 3,000 of the Company's common shares until August 31, 2027 (or the date on which all shares have been sold).
Steven A. Markel
Chair of the Board and a Director of the Company
Adopted 10b5-1 plan Aug 15, 2025 10-Q Oct 29, 2025
What the company wrote
On August 15, 2025, Steven A. Markel, Chair of the Board and a Director of the Company, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to 3,000 of the Company's common shares until August 31, 2026 (or the date on which all shares have been sold).
Steven A. Markel
Chair of the Board and a Director of the Company
Adopted plan Feb 20, 2024 10-Q May 1, 2024
What the company wrote
On February 20, 2024, Steven A. Markel, Chair of the Board and a Director of the Company, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to 3,000 of the Company's common shares until February 14, 2025 (or the date on which all shares have been sold).
Steven A. Markel
Chair of the Board and a Director of the Company
Adopted plan May 31, 2023 10-Q Aug 2, 2023
What the company wrote
On May 31, 2023, Steven A. Markel, Chair of the Board and a Director of the Company, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to 1,398 of the Company's common shares until May 17, 2024 (or the date on which all shares have been sold).

From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since Apr 26, 2023.

Notices of planned sales

Form 144 · Form 144 XML, SEC

What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).

FiledSellerSharesValue
May 22, 2026 Harris Greta J
Director
76 $140K
Dec 11, 2025 MARKEL STEVEN A
Director
1,330 $2.8M
Nov 28, 2025 MARKEL STEVEN A
Director
100 $210K
Nov 26, 2025 MARKEL STEVEN A
Director
70 $147K

From the Form 144 XML filed with the SEC, since Nov 26, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.

Sources

Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.

Also

Insider trades: the Form 4s for the sales these plans led to.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/MKL/export.csv") into a cell.

Next:Owners
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.